WATSON 803 (Meclizine 25 mg)

Pill imprint WATSON 803 has been identified as Meclizine hydrochloride 25 mg.

Meclizine is used in the treatment of vertigo; nausea/vomiting; motion sickness and belongs to the drug class anticholinergic antiemetics. There is no proven risk in humans during pregnancy. Meclizine 25 mg is not subject to the Controlled Substances Act.

See also related documents.

Imprint Search

Images for WATSON 803

Meclizine hydrochloride 25 mg WATSON 803  Front
Meclizine hydrochloride 25 mg WATSON 803  Back
Meclizine hydrochloride 25 mg WATSON 803
Meclizine hydrochloride
Imprint:
WATSON 803
Strength:
25 mg
Color:
White & Yellow
Size:
13.00 mm
Shape:
Elliptical / Oval
Availability:
Rx and/or OTC
Drug Class:
Anticholinergic antiemetics
Pregnancy Category:
B - No proven risk in humans
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Watson Pharmaceuticals
National Drug Code (NDC):
00591-0803
Inactive Ingredients:
silicon dioxide colloidal
corn starch
D&C Yellow No. 10 Lake
lactose monohydrate
microcrystalline cellulose
sodium starch glycolate
stearic acid

View Details Print Page

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide
(web3)